Dendrimer |
Polyethylene glycol (PEG)-platinum |
α-cyclodextrin |
pre-clinical |
[127] |
Polyamidoamine dendrimer |
N-acetyl-cysteine |
clinical/phase I |
[128] |
Micelle |
Polypropylene sulfide-PEG- serine-folic acid zinc phtalocyanine |
doxorubicin |
pre-clinical |
[129] |
PEG-polyaspartate polymeric micelle |
paclitaxel |
clinical/phase III |
[130] |
Carbon nanotube |
PEGylated single walled CNT |
epidermal growth factor (EGF), cisplatin |
pre-clinical |
[131] |
Metallic nanoparticles |
Hollow mesoporous copper sulfide nanoparticle with iron oxides |
doxorubicin |
pre-clinical |
[132] |
Hollow mesoporous copper sulfide nanoparticle with hyaluronic acid |
doxorubicin |
pre-clinical |
[133] |
PEGylated MoS nanosheets |
|
pre-clinical |
[134] |
Azo-functionalized magnetite nanoparticles |
doxorubicin |
pre-clinical |
[135] |
PEGylated gold nanorods (AuNR) |
doxorubicin |
pre-clinical |
[136] |
Iron oxide magnetic silica-gold nanoparticles |
|
clinical/phase I |
[137] |
PEGylated gold nanorod |
aptamer |
pre-clinical |
[138] |
Silica based nanoparticles |
Peptide-functionalized mesoporous silica |
lactobionic acid, doxorubicin |
pre-clinical |
[139] |
Transferrin mesoporous silica |
doxorubicin |
pre-clinical |
[140] |
PEGylated mesoporous silica |
amino-β-cyclodextrin, doxorubicin |
pre-clinical |
[141] |
mesoporous silica |
cytochrome C conjugated lactobionic acid-doxorubicin |
pre-clinical |
[142] |
Hydroxyapatite nano-crystalline nano-structured silica gel |
|
clinical/phase 0 |
[143] |
Nanodiamonds |
PEGylated nanodiamonds |
doxorubicin |
pre-clinical |
[144] |
PEGylated nanodiamonds |
irinotecan, curcumin |
pre-clinical |
[145] |